PMI (NYSEAMERICAN:PMI – Get Free Report) was the target of a large growth in short interest in August. As of August 31st, there was short interest totaling 358,385 shares, a growth of 369.4% from the August 15th total of 76,345 shares. Based on an average daily volume of 7,692,858 shares, the short-interest ratio is currently 0.0 days. Currently, 15.3% of the company’s stock are sold short.
Analyst Upgrades and Downgrades
A number of analysts recently issued reports on the company. HC Wainwright reissued a “neutral” rating on shares of PMI in a research note on Wednesday, June 3rd. Zacks Research upgraded shares of PMI to a “hold” rating in a report on Tuesday, May 19th. Two equities research analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold”.
Get Our Latest Stock Analysis on PMI
PMI Stock Up 14.2%
PMI (NYSEAMERICAN:PMI – Get Free Report) last released its quarterly earnings results on Wednesday, August 19th. The company reported ($3.05) earnings per share for the quarter. PMI had a negative return on equity of 825.18% and a negative net margin of 444.83%.The firm had revenue of $2.95 million for the quarter. On average, sell-side analysts expect that PMI will post -8.5 EPS for the current fiscal year.
PMI Company Profile
Picard Medical Inc is a medical technology company which manufactures and sells the only total artificial heart. Picard Medical Inc is based in TUCSON, Ariz.
See Also
- Five stocks we like better than PMI
- Block Makes a Federal Trust Bank Move That Could Reshape Its Fintech Model
- Kroger’s Textbook Entry for Buy-and-Hold Investors
- AST SpaceMobile Looks to Extend Its 30-Day FCC Satellite Testing Window
- Amgen Drops 10% on a Trial It Didn’t Even Run
Receive News & Ratings for PMI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PMI and related companies with MarketBeat.com's FREE daily email newsletter.
